Esperion unveils positive human trial results for new cholesterol-lowering drug

This article was originally published here

Esperion said that bempedoic acid is under development as a complementary, cost-effective, once-daily and oral therapy to treat patients with elevated LDL-C. The company has submitted new drug

The post Esperion unveils positive human trial results for new cholesterol-lowering drug appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply